Inventor
KOLTUN DMITRY
US36 patents
⚠️ This page may combine multiple inventors who share the name “KOLTUN DMITRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
16 patentsUS11179397B2Nov 23, 2021
Imidazopyrimidine derivatives
GILEAD SCIENCES INC23 citations93
US8697863B2Apr 15, 2014
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC13 citations93
US11939347B2Mar 26, 2024
1′-cyano nucleoside analogs and uses thereof
GILEAD SCIENCES INC7 citations84
US9676760B2Jun 13, 2017
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC7 citations84
US9598435B2Mar 21, 2017
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC9 citations84
US9193694B2Nov 24, 2015
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC11 citations84
US7579504B2Aug 25, 2009
ABCA1 elevating compounds
GILEAD SCIENCES INC8 citations81
US9403782B2Aug 2, 2016
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC4 citations73
US9079901B2Jul 14, 2015
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC5 citations73
US12404289B2Sep 2, 2025
1′-cyano nucleoside analogs and uses thereof
GILEAD SCIENCES INC0 citations61
US11229638B2Jan 25, 2022
Therapeutic heterocyclic compounds
GILEAD SCIENCES INC0 citations61
US11040033B2Jun 22, 2021
Therapeutic heterocyclic compounds
GILEAD SCIENCES INC1 citations61
US9695192B2Jul 4, 2017
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC0 citations52
US9682998B2Jun 20, 2017
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC0 citations52
US10100058B2Oct 16, 2018
Fused heterocyclic compounds as CaM kinase inhibitors
GILEAD SCIENCES INC0 citations41
US8912190B2Dec 16, 2014
Substituted heterocyclic compounds
GILEAD SCIENCES INC0 citations41
CV THERAPEUTICS INC
6 patentsUS6900219B2May 31, 2005
ABCA-1 elevating compounds
CV THERAPEUTICS INC23 citations90
US7407960B2Aug 5, 2008
Substituted heterocyclic compounds
CV THERAPEUTICS INC3 citations63
US7423045B2Sep 9, 2008
ABCA1 elevating compounds
CV THERAPEUTICS INC2 citations62
US7271169B2Sep 18, 2007
Substituted heterocyclic compounds
CV THERAPEUTICS INC0 citations52
US7125876B2Oct 24, 2006
Substituted heterocyclic compounds
CV THERAPEUTICS INC1 citations52
US7432276B2Oct 7, 2008
ABCA1 elevating compounds
CV THERAPEUTICS INC1 citations49
GILEAD PALO ALTO INC
5 patentsUS7625881B2Dec 1, 2009
Prodrugs of A2B adenosine receptor antagonists
GILEAD PALO ALTO INC31 citations92
US7662819B2Feb 16, 2010
Pteridinone derivatives for use as stearoyl CoA desaturase inhibitors
GILEAD PALO ALTO INC15 citations79
US7893066B2Feb 22, 2011
Pyridol[2,3-B]pyrazinones for use as stearoyl CoA desaturase inhibitors
GILEAD PALO ALTO INC5 citations57
US7601721B2Oct 13, 2009
Substituted heterocyclic compounds
GILEAD PALO ALTO INC0 citations52
US7732453B2Jun 8, 2010
Pyrido[2,3-B] pyrazin-3(4H)-ones for use as stearoyl CoA desaturase inhibitors
GILEAD PALO ALTO INC1 citations48
CORKEY BRITTON KENNETH
3 patentsUS8586732B2Nov 19, 2013
Fused heterocyclic compounds as ion channel modulators
CORKEY BRITTON KENNETH29 citations91
US9115096B2Aug 25, 2015
Fused heterocyclic compounds as ion channel modulators
CORKEY BRITTON KENNETH5 citations83
US8962610B2Feb 24, 2015
Fused heterocyclic compounds as ion channel modulators
CORKEY BRITTON KENNETH6 citations83